Nakata Hirotomo

ナカタヒロトモ | Nakata Hirotomo

Affiliation and department：

Research field (1)： Infectious disease

Research keywords (4)：抗HIV薬 , 感染制御 , 感染症 , HIV

Research theme for competitive and other funds (5)：

2022 - 2025 HIV感染におけるケモカイン受容体の動態解析とその多量体形成を標的とした薬剤開発
2021 - 2024 HIV関連神経認知障害(HAND)診断ツールの標準値構築と動作エラーモデルの開発
2018 - 2022 Development of screening measures for detection of HIV-associated neurocognitive disorders (HAND)
2018 - 2021 Elucidation of the mechanism of HIV entry step and the development of novel anti-HIV drug through the analysis of the inhibitory effects on the oligomerization of the chemokine receptors
2014 - 2017 A study of chemokine receptor dynamics and its inhibitor(s) in HIV infection

Papers (45)：

Tomofumi Nakamura, Mayu Okumura, Nobutoki Takamune, Tatsunori Hirotsu, Masaharu Sugiura, Junichiro Yasunaga, Hirotomo Nakata. Conversion of raltegravir carrying a 1,3,4-oxadiazole ring to a hydrolysis product upon pH changes decreases its antiviral activity. PNAS nexus. 2024. 3. 1. pgad446
Kazutaka Oda, Ayami Yamaguchi, Naoya Matsumoto, Hirotomo Nakata, Yusuke Higuchi, Kisato Nosaka, Hirofumi Jono, Hideyuki Saito. Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring. Therapeutic drug monitoring. 2023
Hiro Tatetsu, Yusuke Higuchi, Takafumi Shichijo, Kazutaka Oda, Hirotomo Nakata, Jun-Ichirou Yasunaga, Kisato Nosaka, Masao Matsuoka. Prophylactic effect of tixagevimab-cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma. International journal of hematology. 2023
Kaho Matsumoto, Takeo Kuwata, William D Tolbert, Jonathan Richard, Shilei Ding, Jérémie Prévost, Shokichi Takahama, George P Judicate, Takamasa Ueno, Hirotomo Nakata, et al. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates. Journal of virology. 2023. 97. 1. e0163822
野坂生郷, 立津央, 樋口悠介, 七條敬文, 尾田一貴, 中田浩智, 安永純一朗, 松岡雅雄. B細胞リンパ腫に対してのチキサゲビマブーシルガビマブのCOVID-19発症及び重症化抑制効果. 日本血液学会学術集会. 2022. 84回. 65-65

ｍore...

MISC (44)：

本田伊織, 勝田陽介, 奥村真由, 中村朋文, 中田浩智, 北村祐介, 井原敏博. The suppression of viral gene expression by RNA hacking technology for the development of the anti-HIV drug. 日本分子生物学会年会プログラム・要旨集(Web). 2022. 45th
奥村真由, TRAVIS Chia, 中村朋文, 松岡雅雄, 中田浩智. CXCR4多量体形成阻害からみたHIV-1感染の病態解明. 日本エイズ学会誌. 2022. 24. 4
中村朋文, 奥村真由, 高宗暢暁, 弘津辰徳, 松岡雅雄, 中田浩智. ドラッグデリバリーシステム(DDS)による薬剤の安定性および局在変化による抗HIV-1効果への影響. 日本エイズ学会誌. 2022. 24. 4
CHIA Travis, AMANO Masayuki, NAKAMURA Tomofumi, NAKATA Hirotomo, MATSUOKA Masao. Determining the Mechanism of a Possible HIV-1 Capsid Inhibitor: ACAi-028. 日本エイズ学会誌. 2020. 22. 4
中村朋文, 天野将之, CHIA Travis, 松岡雅雄, 中田浩智. 感染効率を上昇させるHIV-1ヌクレオカプシド内に認められた薬剤耐性変異. 日本エイズ学会誌. 2020. 22. 4

ｍore...

Lectures and oral presentations (7)：

ｍore...

Professional career (1)：

Work history (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page